cro.directory
← Compare landing

Raptim Research vs SMO India Clinical Research Pvt Ltd

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryRaptim ResearchSMO India Clinical Research Pvt Ltd
SummaryBioequivalence and bioavailability specialist with 32+ USFDA inspections cleared, running healthy-subject BA/BE and PK/PD studies, IVRT/IVPT in-vitro release and permeability testing, and Phase I to IV clinical trials.CDSCO-registered CRO with 25+ years of clinical trial experience across Phase I–IV studies in India. Specializes in site management, clinical operations, and regulatory affairs across diverse therapeutic areas.
Services
  • In Vivo PK / PD Studies
  • Bioanalysis
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Quality Control Testing
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Regulatory Affairs
Modalities
  • Biologics (Other)
Data not yet provided.
IndicationsData not yet provided.Data not yet provided.
Phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Sourcing modelsData not yet provided.
  • Full-Service Outsourcing (FSO)
Locations
  • Navi Mumbai, Navi Mumbai, Maharashtra, India
  • Gandhinagar facility, Gandhinagar, Gujarat, India
  • Mumbai Phase I facility, Mumbai, Maharashtra, India
  • Headquarters, Bangalore, India
CertificationsData not yet provided.
  • CDSCO · Identifier: CDSCO-registered

Find similar companies

Raptim Research alternatives · SMO India Clinical Research Pvt Ltd alternatives

Markdown mirror: /compare/raptimresearch/smo-india.md